target directory

vepdegestrant arv 471 pf 07850327 is an oral proteolysis targeting chimera protac designed to selectively degrade estrogen receptors clinical trial intelligence

Trials are included when the normalized target field matches this target directory. Full protocol, result, eligibility and IP analysis is available inside the premium workspace.